Physician profile

Eboni E Vincent

Foot & Ankle Surgery · Irvine, CA

NPI 1457738676

$53,823.22

in general payments reported to CMS, 2019-2025

40 companies · $10K in 2025

The $10K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$22,475.60
Food and Beverage$2,776.75
Travel and Lodging$1,153.84
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$850.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Treace Medical Concepts, INC. $24,113.45 2019-2025
Ossio INC $8,487.15 2021-2024
Pacira Pharmaceuticals Incorporated $6,500.00 2025 Exparel, Zilretta, Iovera
Kerecis Limited $3,183.72 2020-2022
Accufix Surgical INC. $1,497.92 2022
Arthrex, INC. $1,494.71 2019
Vilex LLC $1,465.67 2022
Stryker Corporation $1,120.31 2019-2025 Prostep, Augment Injectable, Hoffmann
Gramercy Extremity Orthopedics LLC $1,092.32 2021
Ortho Dermatologics, A Division of Bausch Health US, LLC $1,012.87 2022-2024 Jublia, Arazlo
Smith+Nephew, INC. $487.25 2020-2025 Pico 7, Renasys Go V2 Home, Renasys Touch
Horizon Therapeutics Plc $359.67 2019-2023 Krystexxa
Musculoskeletal Transplant Foundation INC. $276.63 2020-2022
Integra Lifesciences Corporation $262.25 2019-2021
Inari Medical, INC. $226.14 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Paratek Pharmaceuticals, INC. $221.46 2024-2025 Nuzyra
Tactile Systems Technology INC $218.75 2019-2024 Flexitouch Plus, Entre Plus
Biotissue Holdings INC. $208.93 2024-2025
Bioventus LLC $200.93 2020-2025 Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System
Cardiovascular Systems INC. $176.07 2022
Arthrosurface Incorporated $145.42 2019-2020
Abbott Laboratories $131.53 2025 Eterna
Amgen INC. $121.58 2024 Krystexxa
Bone Support INC. $120.30 2021
Paragon 28, INC. $91.16 2020-2023 Silverback
Anika Therapeutics, INC. $87.49 2021
Wright Medical Technology, INC. $87.02 2019-2020
Angiodynamics, INC. $85.51 2022
Sanara Medtech INC. $71.38 2022
Depuy Synthes Sales INC. $55.46 2024-2025 Na
Zimmer Biomet Holdings, INC. $34.75 2019-2021
Organogenesis INC. $33.90 2021-2022
Mimedx Group, INC. $32.66 2024
Urgo Medical North America, LLC $24.44 2024 Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap
Linvatec Corporation $23.29 2022
Lifenet Health $22.35 2024 Theragenesis Wound Matrix
Glaxosmithkline, LLC. $14.25 2019
Saxum Surgical, INC. $13.21 2022
Ermi LLC $11.46 2020
Bard Peripheral Vascular, INC. $9.86 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eboni E Vincent

$53,823.22

in general payments reported 2019-2025

Years
2019-2025
Top company
Treace Medical Concepts, INC.
Context
The $10K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/1354491/eboni-e-vincent

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.